Clinical Value of SPECT-CT Fusion Imaging in Diagnosis of the Differentiated Thyroid Cancer Metastases

WANG Zhi-guo,ZHANG Wen-wen,HAO Shan-hu,ZHANG Tong,ZHANG Guo-xu

DOI: https://doi.org/10.11748/bjmy.issn.1006-1703.2014.01.016

2014-01-01

Abstract:Objective To explore the clinical value of131I SPECT-CT fusion imaging in location and qualitative diagnosis of metastases of differentiated thyroid carcinoma(DTC).Methods 69 patients who had been diagnosed as differentiated thyroid cancer with total or subtotal resection,took131I orally with treatment dose 3.70 ~ 7.40 GBq.The patients did whole-body planar imaging(131I-WBS) after 5 ~ 7 days,and then performed the SPECT and CT scans at the same bed location.The results were compared with pathological or other imaging examination and clinical follow-up results,to analyze and determine the location and qualitative diagnosis of DTC metastases.Results The total 186 metastases were found in 69 patients.Abnormal131I uptake density collective focus were found in 170 planar imaging and 179 fusion imaging,in which there were 160 planar imaging and 174 fusion imaging that were consistent with the pathological,spiral CT,MRI and ultrasound examination results.The diagnostic sensitivity of planar imaging and SPECT-CT were 86%(160 /186),93.5%(174 /186) respectively.The qualitative and localization accuracy were 81.6%(160 /196),91.1%(174 /191) respectively.There was significantly difference on diagnostic sensitivity and accuracy between two methods(P 0.05).Conclusion131I SPECT-CT fusion imaging can precisely locate and determine the nature of DTC recurrence and metastasis,overcome the influences from pollution focus,organizational overlap and other factors.Compared with planar imaging,it has higher sensitivity and accuracy.It has important clinical value and can be used in clinical staging of DTC patients,curative effect and the setting of treatment programs.